[1]范雪峰,王伦锋,余招焱,等.左侧及右侧中央区淋巴结清扫在甲状腺乳头状癌术中的应用[J].医学信息,2021,34(09):5-7.[doi:10.3969/j.issn.1006-1959.2021.09.002]
　FAN Xue-feng,WANG Lun-feng,YU Zhao-yan,et al.Left and Right Central Lymph Node Dissection in the Operation of Papillary Thyroid Carcinoma[J].Medical Information,2021,34(09):5-7.[doi:10.3969/j.issn.1006-1959.2021.09.002]
点击复制

左侧及右侧中央区淋巴结清扫在甲状腺乳头状癌术中的应用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年09期
页码:
5-7
栏目:
出版日期:
2021-05-01

文章信息/Info

Title:
Left and Right Central Lymph Node Dissection in the Operation of Papillary Thyroid Carcinoma
文章编号:
1006-1959（2021）09-0005-03
作者:
范雪峰; 王伦锋; 余招焱; 等
（1.首钢水钢总医院普外科，贵州 六盘水 553000； 2.贵州省人民医院血管甲状腺外科，贵州 贵阳 550002）
Author(s):
FAN Xue-feng; WANG Lun-feng; YU Zhao-yan; et al.
(1.Department of General Surgery,Shuigang General Hospital,Liupanshui 553000,Guizhou,China; 2.Department of Vascular and Thyroid Surgery,Guizhou Provincial People’s Hospital,Guiyang 550002,Guizhou,China)
关键词:
甲状腺乳头状癌; 中央区淋巴结清扫术; 甲状旁腺功能减退
Keywords:
Papillary thyroid carcinoma; Central lymph node dissection; Hypoparathyroidism
分类号:
R736.1
DOI:
10.3969/j.issn.1006-1959.2021.09.002
文献标志码:
A
摘要:
目的 探讨甲状腺乳头状癌（PTC）术中施行左侧中央区淋巴结清扫术（L-CLND）与右侧中央区淋巴结清扫术（R-CLND）术的差异。方法 回顾性分析2017年6月~2020年5月在首钢水钢总医院初次诊治的138例PTC术中需行单侧CLND患者的临床资料，根据施行中央区淋巴结清扫术（CLND）位置不同分为L-CLND组73例与R-CLND组65例。L-CLND组施行左侧CLND术，R-CLND组施行右侧CLND术，比较两组术后淋巴结清扫数量，淋巴结阳性率及手术并发症发生情况。结果 两组淋巴结转移阳性率、TT术后24 h引流量比较，差异无统计学差异（P＞0.05）。R-CLND组清扫获得平均淋巴结数量多于L-CLND组、LT术后24 h引流量少于L-CLND组、术后住院天数短于L-CLND组，差异有统计学意义（P＜0.05）。两组暂时性RLN损伤及甲旁减的发生率比较，差异无统计学意义（P＞0.05）。结论 左侧及右侧中央区淋巴结的解剖范围及毗邻结构存在一定的临床差异，实施CLND术时应有针对性地避免发生术后相关并发症。
Abstract:
Objective To investigate the difference between the left central area lymph node dissection (L-CLND) and the right central area lymph node dissection (R-CLND) during the operation for papillary thyroid carcinoma (PTC).Methods A retrospective analysis of the clinical data of 138 patients with unilateral CLND who were diagnosed and treated in Shuigang General Hospital from June 2017 to May 2020 was retrospectively analyzed.According to the location of central lymph node dissection (CLND), they were divided into 73 cases in L-CLND group and 65 cases in R-CLND group.The left CLND operation was performed in the L-CLND group, and the right CLND operation was performed in the R-CLND group. The number of postoperative lymph node dissections, the positive rate of lymph nodes and the occurrence of surgical complications were compared between the two groups.Results There was no significant difference in the positive rate of lymph node metastasis between the two groups and the drainage volume at 24 h after TT (P>0.05).The average number of lymph nodes obtained by dissection in the R-CLND group was more than that in the L-CLND group, the drainage volume at 24 h after LT was less than that in the L-CLND group, and the postoperative hospital stay was shorter than that in the L-CLND group,the difference was statistically significant (P<0.05).There was no statistically significant difference in the incidence of temporary RLN injury and hypoparathyroidism between the two groups (P>0.05).Conclusion There are certain clinical differences in the anatomical scope and adjacent structures of the left and right central lymph nodes. CLND should be targeted to avoid postoperative complications.

参考文献/References:

[1]Orloff LA,Kuppersmith RB.American Thyroid Association’s central neck dissection terminology and classification for thyroid cancer consensus statement[J].Otolaryngol Head Neck Surg,2010,142(1):4-5. [2]沈莎莎.基于甲状腺癌灶CT影像组学模型预测中央组淋巴结转移的可行性研究[D].昆明医科大学,2019. [3]王兴,李伟文,邵明涛,等.分化型甲状腺癌中央区淋巴结转移患者临床病理特征及转移危险因素分析[J].肿瘤研究与临床,2020,32(7):493-497. [4]中华医学会内分泌学分会,中华医学会外科学分会,中国抗癌协会头颈肿瘤专业委员会,等.甲状腺结节和分化型甲状腺癌诊治指南[J].中国肿瘤临床,2012,39(17):1249-1272. [5]李元元.引流管早期拔除在甲状腺癌患者术后快速康复中的应用[J].中国社区医师,2016,32(35):1242-1243. [6]中华人民共和国国家卫生健康委.甲状腺癌诊疗规范(2018年版)[J].中华普通外科学文献(电子版),2019,13(1):7-21. [7]隋成秋,梁楠.第8版AJCC甲状腺癌TNM分期系统的更新要点及应用价值[J].中国普通外科杂志,2018,27(11):1464-1470. [8]单云官,张金波,魏焕萍.经皮穿刺胸腺的应用解剖[J].解剖学研究,2005,27(3):183-184. [9]朱精强,田文,苏安平.甲状腺围手术期甲状旁腺功能保护指南(2018版)[J].中国实用外科杂志,2018,38(10):25-30. [10]Zhang DG,Gao L,Miao YW,et al.Risk factors for posterior to right recurrent laryngeal nerve lymph node metastasis in papillary thyroid carcinoma[J].Saudi Medical Journal,2014,35(8):832-837. [11]余招焱,朱昕,袁平,等.超声刀在甲状腺手术中的应用价值及体会[J].山东医药,2017,57(4):93-95. [12]苏畅,徐大海,张文鑫,等.中央区淋巴结清扫对甲状旁腺功能影响[J].中华内分泌外科杂志,2016,10(1):85-87.

相似文献/References:

[1]郑时玉,郭亚男.c-Met及MACC1在甲状腺乳头状癌中的表达及临床意义[J].医学信息,2022,35(15):36.[doi:10.3969/j.issn.1006-1959.2022.15.007]
　ZHENG Shi-yu,GUO Ya-nan.Expression and Clinical Significance of c-Met and MACC1 in Papillary Thyroid Carcinoma[J].Medical Information,2022,35(09):36.[doi:10.3969/j.issn.1006-1959.2022.15.007]
[2]李 想,孙春雷,张 懿,等.无充气腋窝入路腔镜手术治疗甲状腺乳头状癌的疗效研究[J].医学信息,2021,34(04):115.[doi:10.3969/j.issn.1006-1959.2021.04.030]
　LI Xiang,SUN Chun-lei,ZHANG Yi,et al.Study on the Curative Effect of Laparoscopic Surgery Non-inflated Axillary Approach in the Treatment of Papillary Thyroid Carcinoma[J].Medical Information,2021,34(09):115.[doi:10.3969/j.issn.1006-1959.2021.04.030]
[3]刘 彻,艾力·赛丁,苏鹏程.甲状腺乳头状癌颈部淋巴结转移特点及相关危险因素分析[J].医学信息,2019,32(23):70.[doi:10.3969/j.issn.1006-1959.2019.23.019]
　LIU Che,Aili·SaiDing,SU Peng-cheng.Analysis of Cervical Lymph Node Metastasis and Related Risk Factors in Papillary Thyroid Carcinoma[J].Medical Information,2019,32(09):70.[doi:10.3969/j.issn.1006-1959.2019.23.019]
[4]唐嘉晨,郝玲玲,秦晓茹,等.全腔镜下甲状腺乳头状癌并发症Meta分析[J].医学信息,2021,34(04):78.[doi:10.3969/j.issn.1006-1959.2021.04.021]
　TANG Jia-chen,HAO Ling-ling,QIN Xiao-ru,et al.Meta-analysis of Complications of Papillary Thyroid Carcinoma Under Full Laparoscopic Surgery[J].Medical Information,2021,34(09):78.[doi:10.3969/j.issn.1006-1959.2021.04.021]
[5]徐海燕,潘景润,宫希军,等.CT增强联合甲状腺球蛋白及抗体在甲状腺乳头状癌颈部淋巴结转移中的预测价值[J].医学信息,2021,34(20):119.[doi:10.3969/j.issn.1006-1959.2021.20.030]
　XU Hai-yan,PAN Jing-run,GONG Xi-jun,et al.The Value of CT Enhancement Combined with Thyroglobulin and Antibody in PredictingCervical Lymph Node Metastasis of Papillary Thyroid Carcinoma[J].Medical Information,2021,34(09):119.[doi:10.3969/j.issn.1006-1959.2021.20.030]
[6]李佳楠,陈春悠.STAT3、NCK1和VEGF在甲状腺乳头状癌中的表达及临床意义[J].医学信息,2022,35(05):94.[doi:10.3969/j.issn.1006-1959.2022.05.023]
　LI Jia-nan,CHEN Chun-you.Expression of STAT3, NCK1 and VEGF in Papillary Thyroid Carcinoma and its Clinical Significance[J].Medical Information,2022,35(09):94.[doi:10.3969/j.issn.1006-1959.2022.05.023]
[7]李雪松,苏新良,陶冬梅.术前诊断不明确的甲状腺乳头状癌的风险分析[J].医学信息,2024,37(04):119.[doi:10.3969/j.issn.1006-1959.2024.04.021]
　LI Xue-song,SU Xin-liang,TAO Dong-mei.Risk Analysis of Papillary Thyroid Carcinoma with Undefinable Preoperative Diagnosis[J].Medical Information,2024,37(09):119.[doi:10.3969/j.issn.1006-1959.2024.04.021]

更新日期/Last Update: 1900-01-01